Short answer · Medically reviewed summary · Last updated: 2026-04-07
Anosmia, the complete inability to detect odors, is estimated to affect approximately 3% to 20% of the general population, though these figures vary significantly based on age and underlying health factors. While often under-reported, the prevalence of anosmia is notably higher in older adults and those who have experienced viral infections, with clinical data suggesting a higher incidence in males compared to females. What is the estimated prevalence and incidence of Anosmia? Determining the exact prevalence of Anosmia is challenging because it is frequently underdiagnosed or dismissed as a minor symptom of other conditions.
1 people with Anosmia have shared their first-person experience on this question at DiseaseMaps.
Anosmia, the complete inability to detect odors, is estimated to affect approximately 3% to 20% of the general population, though these figures vary significantly based on age and underlying health factors. While often under-reported, the prevalence of anosmia is notably higher in older adults and those who have experienced viral infections, with clinical data suggesting a higher incidence in males compared to females.
Determining the exact prevalence of Anosmia is challenging because it is frequently underdiagnosed or dismissed as a minor symptom of other conditions. Estimates from the National Institutes of Health (NIH) suggest that roughly 3% of the U.S. population experiences a significant loss of smell, while other clinical studies indicate that up to 20% of adults may have some degree of olfactory dysfunction. Incidence rates—the number of new cases per year—are difficult to track, but there has been a documented global surge in Anosmia cases following the COVID-19 pandemic, as viral post-infectious olfactory loss has become a leading cause of the condition.
Anosmia displays a clear correlation with aging. Prevalence increases significantly after age 60, with some studies suggesting that nearly 50% of people over the age of 80 may experience a measurable decline in olfactory function. Regarding gender, clinical literature generally points to a slightly higher prevalence of Anosmia in males compared to females, though the reasons—whether biological, occupational exposure, or hormonal—remain a subject of active research. While pediatric Anosmia exists, it is less common and is often linked to congenital conditions or severe trauma rather than the age-related degeneration seen in seniors.
Accurate statistics for Anosmia are hampered by several clinical and structural challenges. Because smell is often considered a "secondary" sense compared to sight or hearing, patients may not seek medical attention until the loss of smell significantly impacts their quality of life, such as their ability to detect spoiled food or gas leaks. Furthermore, Anosmia is often a symptom of another underlying condition (like chronic sinusitis or neurological disease) rather than a primary diagnosis, leading to frequent misclassification in medical databases. The 513 members of the DiseaseMaps.org community provide a vital, real-world perspective that complements clinical data, highlighting the lived experience of those who are often overlooked in traditional epidemiological surveys.
The risk profile for Anosmia is multifactorial and includes both environmental and biological triggers. Key risk factors that clinicians monitor include:
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.